The Benefits of Rituxan
Learn how Rituxan can treat WG and MPA and put your disease into remission, as well as the potential side effects.
Learn MorePatient Stories
Listen to people talk about their experiences with WG and MPA.
Learn More Share Your StoryFinancial Services & Support
Learn more about Rituxan Access Solutions®, a resource that can help connect you to the medicine you need.
Learn MoreRituxan is the first FDA-approved treatment for adults with Wegener's Granulomatosis (WG) and Microscopic Polyangiitis (MPA)
WHAT IS RITUXAN?
Rituxan® (rituximab) is used with glucocorticoids to treat adults with Wegener's Granulomatosis (WG) and Microscopic Polyangiitis (MPA).
IMPORTANT SIDE EFFECT INFORMATION
Rituxan therapy can result in serious side effects, some of which can be life threatening. These include:
- infusion reactions
- tumor lysis syndrome (TLS)
- severe skin and mouth reactions
- progressive multifocal leukoencephalopathy (PML)
Other serious, potentially life-threatening side effects are:
- hepatitis B infection that may become active again
- serious infections
- heart problems
- low blood cell counts
Common side effects in the WG and MPA study included infections, nausea, diarrhea, headache, muscle spasms, anemia, and peripheral edema (swollen hands and feet).
Before treatment with Rituxan, patients should tell their doctor if they have an infection, including one that will not go away or that keeps coming back.
If patients experience any symptoms or side effects during or after Rituxan treatment, they should seek immediate medical attention.
These are not all of the possible side effects with Rituxan. Tell your doctor about any side effect that bothers you or that does not go away.
Please see full prescribing information, including Medication Guide.
If you have any questions about this information, be sure to discuss them with your doctor.
Rituxan is the first FDA-approved treatment for adults with Wegener's Granulomatosis (WG) and Microscopic Polyangiitis (MPA)